Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: A Fresh Look at the Data Driving Targeted Therapeutic Developments in IgA Nephropathy

Visit https://www.peervoice.com/QXH860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: A Fresh Look at the Data Driving Targeted Therapeutic Developments in IgA Nephropathy”, participants will be able to: Describe the safety and efficacy data, including key endpoints, from trials examining novel B-cell modulator therapies in IgA nephropathy (IgAN); and Appraise the clinical data from recent therapeutic developments, including B-cell modulators, in the context of updated KDIGO recommended treatment targets and approved therapies in the management of IgAN.

Listen